4
Changes in Ownership
KYNTRA BIO, INC. Filed Acc 0001415889-25-008872
CEO bought 145,000 shares at $0.35 ($50,663)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wettig Thane CEO | 2025-03-24 | Purchase | +145,000 | $0.35 | $50,663 | 543,329 | D: show line 1 in the form |
| Open-market purchases · 145,000 sh · avg $0.35 · $50,663 | |||||||
Loading xslF345X05/form4-03252025_090301.xml…